Literature DB >> 27914264

Pattern-based sensing of triple negative breast cancer cells with dual-ligand cofunctionalized gold nanoclusters.

Yu Tao1, Mingqiang Li2, Debra T Auguste3.   

Abstract

Early detection of breast cancer is a critical component in patient prognosis and establishing effective therapy regimens. Here, we developed an easily accessible yet potentially powerful sensor to detect cancer cell targets by utilizing seven dual-ligand cofunctionalized gold nanoclusters (AuNCs) as both effective cell recognition elements and signal transducers. On the basis of this AuNC multichannel sensor, we have successfully distinguished healthy, cancerous and metastatic human breast cells with excellent reproducibility and high sensitivity. Triple negative breast cancer cells (TNBCs), which exhibit low expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2, were identified. The high accuracy of the blind breast cell sample tests further validates the practical application of the sensor array. In addition, the versatility of the sensor array is further justified by identifying amongst distinct cell types, different cell concentrations and cell mixtures. Notably, the drug-resistant cancer cells can also be efficiently discriminated. Furthermore, the dual-ligand cofunctionalized AuNCs can efficiently differentiate different cells from the peripheral blood of tumor-free and tumor-bearing mice. Taken together, this fluorescent AuNCs based array provides a powerful cell analysis tool with potential applications in biomedical diagnostics.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Array-based sensing; Gold nanoclusters; Multi-drug resistance; Triple negative breast cancer

Mesh:

Substances:

Year:  2016        PMID: 27914264      PMCID: PMC5540662          DOI: 10.1016/j.biomaterials.2016.11.050

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  118 in total

1.  Protein sensing and cell discrimination using a sensor array based on nanomaterial-assisted chemiluminescence.

Authors:  Hao Kong; Da Liu; Sichun Zhang; Xingrong Zhang
Journal:  Anal Chem       Date:  2011-02-16       Impact factor: 6.986

2.  ICAM-1 as a molecular target for triple negative breast cancer.

Authors:  Peng Guo; Jing Huang; Liya Wang; Di Jia; Jiang Yang; Deborah A Dillon; David Zurakowski; Hui Mao; Marsha A Moses; Debra T Auguste
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

3.  Discrimination of hemoglobins with subtle differences using an aptamer based sensing array.

Authors:  Min Lin; Wenshan Li; Yaning Wang; Xiaohai Yang; Kemin Wang; Qing Wang; Pei Wang; Yujie Chang; Yuyu Tan
Journal:  Chem Commun (Camb)       Date:  2015-05-14       Impact factor: 6.222

4.  Self-assembled, functionalized graphene and DNA as a universal platform for colorimetric assays.

Authors:  Yu Tao; Youhui Lin; Jinsong Ren; Xiaogang Qu
Journal:  Biomaterials       Date:  2013-03-30       Impact factor: 12.479

5.  Array-based sensing of proteins and bacteria by using multiple luminescent nanodots as fluorescent probes.

Authors:  Yu Tao; Xiang Ran; Jinsong Ren; Xiaogang Qu
Journal:  Small       Date:  2014-05-19       Impact factor: 13.281

6.  Enhanced fluorescence of gold nanoclusters composed of HAuCl4 and histidine by glutathione: glutathione detection and selective cancer cell imaging.

Authors:  Xiaodong Zhang; Fu-Gen Wu; Peidang Liu; Ning Gu; Zhan Chen
Journal:  Small       Date:  2014-08-11       Impact factor: 13.281

7.  Chemical nose sensors: an alternative strategy for cancer diagnosis.

Authors:  Ngoc D B Le; Subinoy Rana; Vincent M Rotello
Journal:  Expert Rev Mol Diagn       Date:  2013-03       Impact factor: 5.225

8.  Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer.

Authors:  Sébastien Toffoli; Isabelle Bar; Fadi Abdel-Sater; Paul Delrée; Pascale Hilbert; Frédéric Cavallin; Fabrice Moreau; Wim Van Criekinge; Magali Lacroix-Triki; Mario Campone; Anne-Laure Martin; Henri Roché; Jean-Pascal Machiels; Javier Carrasco; Jean-Luc Canon
Journal:  Breast Cancer Res       Date:  2014-11-22       Impact factor: 6.466

9.  Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer.

Authors:  P Mathew; P F Thall; S Wen; C Bucana; D Jones; E Horne; W K Oh; M J Morris; Y-C Lee; C J Logothetis; S-H Lin; I J Fidler
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

10.  miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.

Authors:  Xiaohui Tan; Jin Peng; Yebo Fu; Shejuan An; Katayoon Rezaei; Sana Tabbara; Christine B Teal; Yan-gao Man; Rachel F Brem; Sidney W Fu
Journal:  Breast Cancer Res       Date:  2014-09-17       Impact factor: 6.466

View more
  4 in total

1.  Cyclodextrin-Promoted Fluorescence Detection of Aromatic Toxicants and Toxicant Metabolites in Commercial Milk Products.

Authors:  Dana J DiScenza; Julie Lynch; Molly Verderame; Melissa A Smith; Mindy Levine
Journal:  Food Anal Methods       Date:  2018-03-14       Impact factor: 3.366

Review 2.  Array-based "Chemical Nose" Sensing in Diagnostics and Drug Discovery.

Authors:  Yingying Geng; William J Peveler; Vincent M Rotello
Journal:  Angew Chem Int Ed Engl       Date:  2019-02-20       Impact factor: 15.336

Review 3.  Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities.

Authors:  Sylvia Annabel Dass; Kim Liu Tan; Rehasri Selva Rajan; Noor Fatmawati Mokhtar; Elis Rosliza Mohd Adzmi; Wan Faiziah Wan Abdul Rahman; Tengku Ahmad Damitri Al-Astani Tengku Din; Venugopal Balakrishnan
Journal:  Medicina (Kaunas)       Date:  2021-01-12       Impact factor: 2.430

Review 4.  Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters.

Authors:  Alioscka A Sousa; Peter Schuck; Sergio A Hassan
Journal:  Nanoscale Adv       Date:  2021-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.